Anheuser-Busch InBev stock slumps over 3% as institutional selling and technical weakness weigh

Traders Union
All News
Stocks
Anheuser-busch inbev slides 3.07% today

Highlights

Anheuser-Busch InBev reported EUR 59.8 billion in revenue and USD 15.3 billion in normalized EBITDA for 2025, with volumes at 107.3 billion hectoliters.
Glenmede Trust Co. NA reduced its stake in the company by 72.8% in the first quarter, now holding 5,333 shares.
Shares of Anheuser-Busch InBev trade under near-term pressure with a forecast range of $78.19 to $82.23, as mixed momentum and oversold signals suggest continued volatility.

Ownership reductions and strong earnings fail to offset continued share pressure

Anheuser-Busch InBev reported 2025 financial results showing EUR 59.8 billion in revenue, USD 15.3 billion in normalized EBITDA, and volumes reaching 107.3 billion hectoliters. Regulatory disclosures revealed Glenmede Trust Co. NA reduced its stake in the company by 72.8% during the first quarter, now holding 5,333 shares. These operational and ownership updates were recorded, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, highlights significant near-term risk for Anheuser-Busch InBev after notable institutional selling, particularly the drastic reduction by Glenmede Trust Co. NA. He sees technical signals confirming prevailing downside pressure as the price remains under key moving averages, despite the company’s strong reported figures. Momentum divergences and oversold oscillators point to uncertain price action and a weak sentiment backdrop. Kharitonov stresses that buyers are failing to generate a convincing reversal, and downside risks persist near $78.19. "Until institutional flows stabilize and technical strength returns, I am skeptical about sustainable upside for BUD here."

Viktoras Karapetjanc, expert at Traders Union, sees Anheuser-Busch InBev’s long-term bullish structure as intact even amid short-term volatility. He notes robust fundamentals, with strong 2025 financials and volumes supporting the company's market leadership. Karapetjanc highlights that the technical base above the 200-day average and a 65% probability of upside favor further growth. He believes short-term selling offers constructive setups for investors with a multi-session horizon. "With key support holding and fundamentals strong, I expect BUD to regain positive momentum above $81.35 soon."

Jainam Mehta, market strategist, takes a balanced view on BUD, focusing on the mixed technical landscape. Mehta observes the divergence between bullish MACD momentum and oversold short-term indicators, suggesting tactical trading opportunities could emerge soon. He sees a sideways scenario with the possibility of a sharp move if price breaks either $81.35 or $80.41. "A potential contrarian entry may appear if sentiment remains weak despite improving momentum readings."

Short-term weakness persists despite mixed momentum and support above 200-day

BUD is currently below its 20-day and 50-day moving averages, at $82.76 and $81.69 respectively, but holds above the long-term 200-day moving average of $73.21. This setup indicates sustained short-term selling, a stressed intermediate trend, and continuing long-term support, with resistance at $81.35 and support at $80.41. Momentum signals are mixed: MACD reflects strong bullish momentum, but the ADX at 11.7 suggests a neutral underlying trend. The RSI stands at 51.26 with a Buy forecast, while the Stochastic RSI is near oversold at 15.86. CCI is neutral and Bull/Bear Power at -0.4 shows sellers dominate intraday momentum. The oscillators diverge, with oversold technical readings against bullish MACD momentum, signaling caution.

Earlier, analysts noted that Anheuser-Busch InBev was exhibiting short-term technical weakness within a broader, structurally bullish long-term trend. The latest data on institutional selling and mixed momentum signals increases the risk of downside moves, making the $80.41 support a critical level to monitor for a potential shift in near-term direction.

Source of Data: BUD Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.